Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephroblastoma (Wilms Tumour)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00562640
What this trial is testing

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01220128
What this trial is testing

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 66
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Early research (Phase 1)Study completedNCT01445379
What this trial is testing

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Who this might be right for
SarcomaWilm's TumorLymphoma+1 more
National Cancer Institute (NCI) 33
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Large-scale testing (Phase 3)Study completedNCT00002610
What this trial is testing

Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors

Who this might be right for
Kidney Cancer
Children's Oncology Group 203
Early research (Phase 1)Study completedNCT01440920
What this trial is testing

A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Otsuka Pharmaceutical Co., Ltd. 9
Not applicableStudy completedNCT00674193
What this trial is testing

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaChildhood RhabdomyosarcomaChildhood Soft Tissue Sarcoma+5 more
Children's Oncology Group 158
Not applicableActive Not RecruitingNCT07586332
What this trial is testing

INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA

Who this might be right for
Indirect Inguinal HerniaUndescended Testis
Trakya University 3
Early research (Phase 1)Study completedNCT05360680
What this trial is testing

In Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Who this might be right for
Colorectal CancerGastric CancerPancreatic Cancer+1 more
Cue Biopharma 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00834002
What this trial is testing

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Antwerp 10
Testing effectiveness (Phase 2)Looking for participantsNCT06456359
What this trial is testing

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorSynovial Sarcoma
University Hospital Heidelberg 28
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01614808
What this trial is testing

Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor

Who this might be right for
Recurrent Wilms Tumor and Other Childhood Kidney TumorsStage III Wilms Tumor
Children's Oncology Group 90
Testing effectiveness (Phase 2)Study completedNCT01291420
What this trial is testing

Dendritic Cell Vaccination for Patients with Solid Tumors

Who this might be right for
GlioblastomaRenal Cell CarcinomaSarcomas+3 more
University Hospital, Antwerp 48
Testing effectiveness (Phase 2)Study completedNCT00187031
What this trial is testing

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

Who this might be right for
Wilms Tumor
St. Jude Children's Research Hospital 37
Not applicableUnknownNCT00503893
What this trial is testing

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Who this might be right for
Wilms' TumorAniridia
M.D. Anderson Cancer Center 295
Early research (Phase 1)Study completedNCT00011414
What this trial is testing

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Who this might be right for
Wilms' TumorSarcomaAdenaocortical Carcinoma+2 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Next Page